Sep 14, 2022 / 02:35PM GMT
Vikram Purohit - Morgan Stanley, Research Division - Equity Analyst
Welcome everyone. My name is Vikram Purohit, I'm one of the biotech analysts with Morgan Stanley Research. This is the fireside chat with Exscientia. Let me read a brief disclosure before we get started. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative. With that, very happy to have with me CFO and CSO Ben Taylor and COO, Dave Hallett. Dave, Ben, thanks for joining us.
Before we dive into specifics on the pipeline, Ben and Dave, could you provide some opening remarks on just a brief overview of the company, the platform, kind of the court thesis for why the company was formed and some of the key milestones you think you've hit throughout the course of the year?
Ben R. Taylor - Exscientia plc - CFO, Chief Strategy Officer & Executive
Exscientia PLC at Morgan Stanley Global Healthcare Conference Transcript
Sep 14, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers